首页> 外文期刊>Nature >T-helper-1-cell cytokines drive cancer into senescence
【24h】

T-helper-1-cell cytokines drive cancer into senescence

机译:T-helper-1-细胞细胞因子促使癌症衰老

获取原文
获取原文并翻译 | 示例
       

摘要

Cancer control by adaptive immunity involves a number of defined death and clearance mechanisms. However, efficient inhibition of exponential cancer growth by T cells and interferon-γ (IFN-γ) requires additional undefined mechanisms that arrest cancer cell proliferation. Here we show that the combined action of the T-helper-1-cell cytokines IFN-γ and tumour necrosis factor (TNF) directly induces permanent growth arrest in cancers. To safely separate senescence induced by tumour immunity from oncogene-induced senescence, we used a mouse model in which the Simian virus 40 large T antigen (Tag) expressed under the control of the rat insulin promoter creates tumours by attenuating p53- and Rb-mediated cell cycle control. When combined, IFN-γ and TNF drive Tag-expressing cancers into senescence by inducing permanent growth arrest in G1/G0, activation of p16INK4a (also known as CDKN2A), and downstream Rb hypo-phosphorylation at serine 795. This cytokine-induced senescence strictly requires STAT1 and TNFR1 (also known as TNFRSF1A) signalling in addition to p16INK4a. In vivo, Tag-specific T-helper 1 cells permanently arrest Tag-expressing cancers by inducing IFN-γ- and TNFR1-dependent senescence. Conversely, Tnfr1~(-/-) Tag-expressing cancers resist cytokine-induced senescence and grow aggressively, even in TNFR1-expressing hosts. Finally, as IFN-γ and TNF induce senescence in numerous murine and human cancers, this may be a general mechanism for arresting cancer progression.
机译:通过适应性免疫的癌症控制涉及许多确定的死亡和清除机制。但是,T细胞和干扰素-γ(IFN-γ)有效抑制指数癌症的生长需要阻止癌细胞增殖的其他不确定机制。在这里,我们显示T辅助1细胞因子IFN-γ和肿瘤坏死因子(TNF)的联合作用直接诱导癌症的永久性生长停滞。为了安全地将肿瘤免疫诱导的衰老与癌基因诱导的衰老区分开,我们使用了小鼠模型,其中在大鼠胰岛素启动子控制下表达的猿猴病毒40大T抗原(Tag)通过减弱p53和Rb介导的方式创建肿瘤细胞周期控制。组合使用时,IFN-γ和TNF通过诱导G1 / G0中的永久性生长停滞,p16INK4a(也称为CDKN2A)的活化以及丝氨酸795下游的Rb低磷酸化而使表达Tag的癌症进入衰老状态。这种细胞因子诱导的衰老。除了p16INK4a之外,严格要求STAT1和TNFR1(也称为TNFRSF1A)信号传导。在体内,标签特异性T-helper 1细胞通过诱导IFN-γ和TNFR1依赖性衰老而永久性地阻止表达标签的癌症。相反,即使在表达TNFR1的宿主中,表达Tnfr1〜(-/-)标签的癌症也能抵抗细胞因子诱导的衰老,并能迅速生长。最后,由于IFN-γ和TNF在许多鼠类和人类癌症中诱导衰老,这可能是阻止癌症进展的一般机制。

著录项

  • 来源
    《Nature》 |2013年第7437期|361-365|共5页
  • 作者单位

    Department of Dermatology, Eberhard Karls University, Liebermeister Strasse 25, 72076 Tubingen, Germany;

    Department of Dermatology, Eberhard Karls University, Liebermeister Strasse 25, 72076 Tubingen, Germany;

    Department of Dermatology, Eberhard Karls University, Liebermeister Strasse 25, 72076 Tubingen, Germany;

    Department of Dermatology, Eberhard Karls University, Liebermeister Strasse 25, 72076 Tubingen, Germany;

    Department of Dermatology, Eberhard Karls University, Liebermeister Strasse 25, 72076 Tubingen, Germany;

    Department of General Pediatrics, Oncology/Hematology, Eberhard Karls University, Hoppe-Seyler-Strasse 1, 72076 Tubingen, Germany;

    Department of General Pediatrics, Oncology/Hematology, Eberhard Karls University, Hoppe-Seyler-Strasse 1, 72076 Tubingen, Germany;

    lnterfaculty institute for Biochemistry, Eberhard Karls University, Hoppe-Seyler-Strasse 4, 72076 Tubingen, Germany;

    Department of Dermatology, Eberhard Karls University, Liebermeister Strasse 25, 72076 Tubingen, Germany;

    Department of Dermatology, Eberhard Karls University, Liebermeister Strasse 25, 72076 Tubingen, Germany,Laboratory for Preclinical Imaging and imaging Technology of the Werner Siemens-Foundation, Department for Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Roentgenweg 13, 72076 Tubingen, Germany;

    Department of Internal Medicine IV, Endocrinology, Diabetology and Clinical Chemistry, Eberhard Karls University, Otfried-Mueller-Strasse 10, 72076 Tuebingen, Germany;

    Department of Internal Medicine IV, Endocrinology, Diabetology and Clinical Chemistry, Eberhard Karls University, Otfried-Mueller-Strasse 10, 72076 Tuebingen, Germany;

    lnstitut fuer Molekulare Immunologie, Helmholtz-Zentrum Muenchen, Deutsches Forschungszentrum fuer Gesundheit und Umwelt, Marchiomni Strasse 25, 81377 Muenchen, Germany;

    Department of Dermatology, Eberhard Karls University, Liebermeister Strasse 25, 72076 Tubingen, Germany;

    Department of Dermatology, Eberhard Karls University, Liebermeister Strasse 25, 72076 Tubingen, Germany;

    Department of Dermatology, Eberhard Karls University, Liebermeister Strasse 25, 72076 Tubingen, Germany;

    Department of Dermatology, Eberhard Karls University, Liebermeister Strasse 25, 72076 Tubingen, Germany;

    Department of Dermatology, Eberhard Karls University, Liebermeister Strasse 25, 72076 Tubingen, Germany;

    Department of Dermatology, Eberhard Karls University, Liebermeister Strasse 25, 72076 Tubingen, Germany;

    Clinic of Oncology, University Hospital Zurich, Raemistrasse 100,8091 Zurich, Switzerland;

    Department of Internal Medicine IV, Endocrinology, Diabetology and Clinical Chemistry, Eberhard Karls University, Otfried-Mueller-Strasse 10, 72076 Tuebingen, Germany;

    Department of General Pediatrics, Oncology/Hematology, Eberhard Karls University, Hoppe-Seyler-Strasse 1, 72076 Tubingen, Germany,Comprehensive Cancer Center Tubingen, German Cancer Consortium (DKTK), Herrenberger Strasse 23, D-72070 Tuebingen, Germany;

    Department of Pathology, Eberhard Karls University, Liebermeister Strasse 8,72076 Tuebingen, Germany;

    Comprehensive Cancer Center Tubingen, German Cancer Consortium (DKTK), Herrenberger Strasse 23, D-72070 Tuebingen, Germany,Department of Pathology, Eberhard Karls University, Liebermeister Strasse 8,72076 Tuebingen, Germany;

    Division of Molecular Oncology of Solid Tumors, Department of Internal Medicine I, Eberhard Karls University, Otfried-Mueller-Strasse 10, 72076 Tuebingen, Germany;

    Department of Dermatology, Eberhard Karls University, Liebermeister Strasse 25, 72076 Tubingen, Germany;

    Division of Molecular Oncology of Solid Tumors, Department of Internal Medicine I, Eberhard Karls University, Otfried-Mueller-Strasse 10, 72076 Tuebingen, Germany;

    Department of Dermatology, Eberhard Karls University, Liebermeister Strasse 25, 72076 Tubingen, Germany;

    lnterfaculty institute for Biochemistry, Eberhard Karls University, Hoppe-Seyler-Strasse 4, 72076 Tubingen, Germany,Comprehensive Cancer Center Tubingen, German Cancer Consortium (DKTK), Herrenberger Strasse 23, D-72070 Tuebingen, Germany;

    Department of Dermatology, Eberhard Karls University, Liebermeister Strasse 25, 72076 Tubingen, Germany,Comprehensive Cancer Center Tubingen, German Cancer Consortium (DKTK), Herrenberger Strasse 23, D-72070 Tuebingen, Germany;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:53:28

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号